Not available
Quote | Gemphire Therapeutics Inc. (NASDAQ:GEMP)
Last: | $ |
---|---|
Change Percent: | -0.37% |
Open: | $0.3076 |
Close: | $0.30 |
High: | $0.34 |
Low: | $0.2902 |
Volume: | 190,052 |
Last Trade Date Time: | 12/30/2019 04:54:18 pm |
News | Gemphire Therapeutics Inc. (NASDAQ:GEMP)
NeuroBo Pharmaceuticals (NRBO) perks up 6% premarket after receiving approval of an amendment to its Contingent Value Rights ((CVR)) agreement from a majority of CVR holders. The CVRs were distributed to the holders of Gemphire Therapeutics (GEMP) common stock on December 30, 2019, ...
ANN ARBOR, Mich., Dec. 30, 2019 (GLOBE NEWSWIRE) -- The pending merger between Gemphire Therapeutics Inc. (NASDAQ:GEMP) and NeuroBo Pharmaceuticals, Inc. is currently expected to close after market hours today, Monday, December 30, 2019, subject to satisfaction or waiver of all closing cond...
Message Board Posts | Gemphire Therapeutics Inc. (NASDAQ:GEMP)
Subject | By | Source | When |
---|---|---|---|
Why does this keep dropping with merger news? | Cowman45 | investorshub | 12/06/2019 2:38:13 PM |
Ok the 8k on the 9th, item 3.01, | Cowman45 | investorshub | 08/15/2019 6:24:59 PM |
A lot of form 4s yesterday for acquiring shares..... | Cowman45 | investorshub | 07/27/2019 9:29:19 PM |
* * $GEMP Video Chart 07-25-2019 * * | ClayTrader | investorshub | 07/25/2019 8:34:24 PM |
In 1.09 lets go | stock1ace1 | investorshub | 07/25/2019 1:30:58 PM |
News, Short Squeeze, Breakout and More Instantly...
Gemphire Therapeutics Inc. Company Name:
GEMP Stock Symbol:
NASDAQ Market:
Gemphire Therapeutics Inc. Website:
ANN ARBOR, Mich., Dec. 30, 2019 (GLOBE NEWSWIRE) -- The pending merger between Gemphire Therapeutics Inc. (NASDAQ:GEMP) and NeuroBo Pharmaceuticals, Inc. is currently expected to close after market hours today, Monday, December 30, 2019, subject to satisfaction or waiver of all closing cond...
ANN ARBOR, Mich., Dec. 06, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP) announced today that, based upon the final vote count certified by the independent inspector of elections for the annual meeting of stockholders held December 6, 2019, its stockholders approved all ...
LIVONIA, Mich., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company developing and commercializing therapies for the treatment of dyslipidemia, a serious medical condition that increases the risk of life-threatening cardiova...